| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥344.5B | ¥372.4B | -7.5% |
| Operating Income | ¥24.3B | ¥45.8B | -47.1% |
| Ordinary Income | ¥30.6B | ¥46.8B | -34.6% |
| Net Income | ¥33.0B | ¥42.3B | -22.0% |
| ROE | 5.2% | 7.2% | - |
FY2025 Q3 cumulative results show Hodogaya Chemical reported revenue of 344.5B yen (YoY -7.5%), operating income of 24.3B yen (YoY -47.1%), ordinary income of 30.6B yen (YoY -34.6%), and net income attributable to owners of parent of 19.9B yen (YoY -30.9%). This represents a revenue down/profit down pattern with profitability deteriorating more severely than the top-line decline. Operating margin compressed to 7.0% from the prior year, reflecting challenges in cost absorption amid volume contraction. Basic EPS declined 31.0% YoY to 125.27 yen. Despite operating profit pressure, non-operating income including dividends received of 3.7B yen and FX gains of 2.7B yen provided partial support to ordinary income. The company maintained strong cash generation with operating cash flow of 51.4B yen (YoY +9.6%), exceeding net income by 2.58 times, though working capital efficiency deteriorated notably.
Revenue declined 7.5% YoY to 344.5B yen, driven by broad-based weakness across major segments. The top-line contraction stems from reduced customer demand and unfavorable product mix, with external sales declining from 372.4B yen to 344.5B yen. Gross profit margin held at 38.8% with gross profit of 133.7B yen, indicating that cost of sales declined proportionally with revenue. However, SG&A expenses of 109.5B yen remained relatively fixed at 31.8% of sales, up from lower levels in the prior period, creating negative operating leverage. The operating income decline of 47.1% to 24.3B yen significantly exceeded the revenue decline rate, resulting in operating margin compression to 7.0%.
On the profit side, non-operating items provided 6.3B yen net contribution (non-operating income 8.1B yen less non-operating expenses 1.7B yen), narrowing the gap between operating income of 24.3B yen and ordinary income of 30.6B yen. Key non-operating income components included dividends received of 3.7B yen, FX gains of 2.7B yen, and interest income of 0.8B yen. Extraordinary items were minimal with net extraordinary loss of 0.04B yen, including impairment loss of 0.5B yen partially offset by gain on sale of securities of 1.4B yen. The negative income tax expense of -2.3B yen resulted in an effective tax rate of -7.5%, likely reflecting deferred tax adjustments and tax benefits. Non-controlling interests claimed 13.1B yen of net income, bringing net income attributable to owners of parent to 19.9B yen. This represents a revenue down/profit down scenario where both top-line weakness and operating deleverage compressed profitability, though non-operating income and tax adjustments mitigated the full impact on bottom-line earnings.
Functional Colorants segment remains the core business with revenue of 191.6B yen (55.6% of total) and operating income of 24.6B yen at 12.8% margin, though revenue declined 6.3% YoY from 202.1B yen and operating profit fell 38.6% from 40.0B yen. This segment produces toner charge control agents, organic photoconductor materials, OLED materials, bio-materials, and various dyes. Specialty Polymers segment recorded revenue of 55.9B yen but swung to operating loss of -3.8B yen (margin -6.9%), deteriorating significantly from prior period profit of 0.04B yen on revenue of 65.0B yen. This segment covers urethane materials, adhesives, building materials, and pharmaceutical/electronic material intermediates, with the current period impairment loss of 50 million yen in this segment. Basic Chemicals segment generated revenue of 56.8B yen with operating income of 1.9B yen (margin 3.3%), relatively stable compared to prior period revenue of 59.1B yen and operating income of 2.6B yen. This segment supplies hydrogen peroxide and derivatives. AgroScience segment reported revenue of 31.1B yen with operating loss of -1.2B yen (margin -3.9%), declining from prior period revenue of 34.4B yen and operating profit of 0.6B yen. Products include herbicides, insecticides, and oxygen supply agents. Logistics segment contributed revenue of 24.1B yen with operating income of 2.6B yen (margin 10.7%), showing resilience with modest revenue decline from 24.8B yen but stable profitability from prior period operating income of 2.6B yen. The segment handles warehousing, freight forwarding, and ISO tank container storage. The sharp profitability deterioration in Functional Colorants and the losses in Specialty Polymers and AgroScience indicate structural challenges requiring operational improvement across multiple business lines.
[Profitability] ROE of 5.2% declined from healthier levels, with the reported ROE of 3.1% reflecting parent company attribution adjustments. Operating margin of 7.0% compressed significantly as fixed costs were not absorbed by lower revenue volumes. Net profit margin of 9.6% benefited from non-operating income support, though operating margin deterioration indicates core business profitability pressure. [Cash Quality] Cash and equivalents of 116.6B yen provide strong liquidity with cash coverage of short-term liabilities at 2.32 times. Operating cash flow of 51.4B yen represents 2.58 times net income, confirming solid cash earnings quality despite profit decline. [Investment Efficiency] Asset turnover of 0.394 remains below industry median of 0.56, indicating suboptimal asset utilization. Working capital efficiency deteriorated with DSO extending to 117 days, DIO reaching 153 days, and cash conversion cycle stretching to 266 days, all significantly exceeding industry benchmarks and warranting immediate management attention. [Financial Health] Equity ratio of 72.8% exceeds industry median of 63.8%, reflecting conservative capital structure. Current ratio of 262.1% and quick ratio of 200.4% demonstrate ample short-term liquidity well above industry median of 2.87x. Debt-to-equity ratio of 0.37 indicates low financial leverage compared to industry median of 1.53, though interest-bearing debt of 94.6B yen includes notable increase in long-term borrowings of 43.5% YoY to 44.3B yen.
Operating cash flow of 51.4B yen represents 2.58 times net income of 19.9B yen, confirming cash-backed earnings quality. Operating cash flow before working capital changes of 57.0B yen included depreciation and amortization of 25.2B yen, with working capital providing modest contribution through inventory decrease of 1.7B yen and receivables decrease contributing 8.1B yen, while payables increase added 2.6B yen. Income taxes paid of 10.2B yen and interest and dividends received of 5.1B yen were key cash items. Investing cash flow of -35.0B yen was primarily driven by capital expenditures estimated at 45.3B yen, indicating continued investment in capacity despite operating profit pressure, with proceeds from investment securities providing partial offset. Financing cash flow of 0.1B yen was minimal with negligible share repurchases of 0.01B yen and dividend payments absorbing available cash. Free cash flow of 16.4B yen remains positive though constrained by elevated capital expenditure, with FCF coverage of dividends at 1.08 times indicating sustainability at current payout levels but limited buffer for dividend growth or additional shareholder returns without operational improvement.
Ordinary income of 30.6B yen versus operating income of 24.3B yen shows non-operating net contribution of approximately 6.3B yen, comprising primarily dividends received of 3.7B yen, FX gains of 2.7B yen net of FX losses of 1.5B yen, and interest income of 0.8B yen less interest expense of 0.8B yen. Non-operating income represents 2.4% of revenue, with dividends and FX gains as principal components providing cushion to operating profit weakness. Extraordinary items netted to -0.04B yen with impairment loss of 0.5B yen in Functional Colorants segment offset by gain on sale of securities of 1.4B yen, indicating limited one-time distortions to core earnings. The negative effective tax rate of -7.5% reflects deferred tax asset recognition of 18.6B yen and deferred tax liabilities of 26.2B yen on the balance sheet, with current period tax expense of -2.3B yen suggesting tax adjustments or loss carryforward benefits. Operating cash flow exceeding net income by 2.58 times with operating CF to EBITDA ratio of 1.04 times indicates healthy earnings quality with limited accrual-based distortion. However, working capital deterioration with DSO of 117 days and DIO of 153 days signals potential earnings quality concerns if receivables or inventory require future writedowns, warranting close monitoring of asset realizability.
Full-year guidance projects revenue of 470.0B yen (YoY -3.2%), operating income of 35.0B yen (YoY -28.2%), and ordinary income of 35.0B yen (YoY -26.6%), with no revisions during the current quarter. Q3 cumulative progress rates stand at 73.3% for revenue, 69.4% for operating income, and 87.5% for ordinary income against full-year targets. Operating income progress of 69.4% trails the standard expectation of 75% at Q3, suggesting potential shortfall risk or assumption of stronger Q4 seasonal contribution. The ordinary income progress rate of 87.5% exceeds operating income progress, reflecting front-loaded non-operating income contributions and implying Q4 ordinary income may align closely with operating income absent further non-operating gains. EPS forecast of 125.86 yen aligns with Q3 cumulative basic EPS of 125.27 yen, indicating minimal expected Q4 earnings contribution. Contract liabilities of 0.8B yen provide limited forward revenue visibility, calculating to a backlog-to-revenue ratio of 0.2% on annualized basis, insufficient to indicate secured future revenue pipeline. Management notes that forecasts are based on currently available information and actual results may differ due to various factors, with no specific assumptions disclosed regarding FX rates, volume recovery, or cost initiatives.
Annual dividend of 25.00 yen per share is planned for FY2025 following a 2-for-1 stock split effective April 1, 2025, equivalent to 50.00 yen pre-split basis. The company paid interim dividend of 45.00 yen and expects final dividend of 45.00 yen on pre-split basis for FY2024, totaling 90.00 yen. Dividend payout ratio of 76.1% exceeds the sustainability threshold of 60%, raising concerns about dividend coverage amid profit decline. Free cash flow of 16.4B yen provides FCF coverage ratio of 1.08 times estimated dividend payments, indicating current payout is technically supported by cash generation but leaves minimal cushion for flexibility. Share repurchases were negligible at 0.01B yen during the period, resulting in total shareholder return ratio approximating the dividend payout ratio of 76.1%. The elevated payout ratio in context of 31.0% EPS decline and 47.1% operating income decline suggests management commitment to maintaining dividend stability, though sustainability depends on operational recovery and working capital normalization to restore profitability and cash flow margins.
Revenue contraction risk remains elevated as Q3 cumulative revenue declined 7.5% YoY with full-year guidance projecting continued 3.2% decline, indicating structural demand weakness across core segments particularly Functional Colorants where revenue fell 6.3% and operating profit dropped 38.6%, compounded by operating losses in Specialty Polymers of -3.8B yen and AgroScience of -1.2B yen requiring business model reassessment. Working capital deterioration presents significant cash flow risk with DSO of 117 days exceeding industry median of 85 days by 37%, DIO of 153 days versus industry median of 112 days, and cash conversion cycle of 266 days more than double industry benchmarks, indicating potential inventory obsolescence exposure given finished goods of 88.4B yen, raw materials of 30.7B yen, and work in process of 18.5B yen totaling 137.6B yen inventory requiring close monitoring for writedown risk. Refinancing risk warrants attention as short-term debt ratio of 53.1% indicates maturity concentration, with long-term borrowings increasing 43.5% YoY to 44.3B yen suggesting debt restructuring activity, though interest coverage ratio of 31.10 times and current ratio of 262.1% provide adequate near-term protection against liquidity stress absent further profit deterioration.
[Industry Position] (Reference - Proprietary Analysis)
Hodogaya Chemical's profitability metrics trail industry medians with ROE of 5.2% below industry median of 5.8%, operating margin of 7.0% below industry median of 8.9%, and net profit margin of 9.6% above industry median of 6.5% due to non-operating income support. Financial health indicators exceed industry standards with equity ratio of 72.8% above industry median of 63.8% and current ratio of 262.1% significantly above industry median of 2.87x, reflecting conservative balance sheet positioning. Operational efficiency shows material underperformance with asset turnover of 0.394 below industry median of 0.56, inventory turnover of 153 days above industry median of 112 days, receivables turnover of 117 days above industry median of 85 days, and cash conversion cycle of 266 days substantially exceeding industry median of 112 days, indicating working capital management requires urgent improvement. Revenue growth of -7.5% YoY significantly underperforms industry median growth of 2.8%, while EPS decline of 31.0% contrasts unfavorably with industry median EPS growth of 9.0%. Capital allocation shows CapEx to D&A ratio estimated above 1.8x compared to industry median of 1.44x, suggesting elevated investment intensity relative to depreciation base. Financial leverage of 1.37 times remains below industry median of 1.53 times, and net debt to EBITDA of approximately 0.75 times compares favorably to industry median of -1.11 times (net cash position), though the company's positive net debt position differs from industry tendency toward net cash. The company's operating performance lags industry peers across growth and efficiency dimensions while maintaining superior financial stability, indicating strategic focus on balance sheet strength but operational execution challenges requiring management attention.
※ Industry: Manufacturing (105 companies), Comparison: FY2025 Q3, Source: Proprietary analysis
Operating margin compression from industry-leading levels to below-median 7.0% alongside 47.1% operating income decline indicates structural profitability challenges requiring cost structure realignment and revenue stabilization, with particular focus needed on Specialty Polymers segment loss of -3.8B yen and Functional Colorants profit decline of 38.6% despite maintaining 12.8% margin. Working capital efficiency deterioration with DSO of 117 days, DIO of 153 days, and CCC of 266 days substantially exceeding industry benchmarks signals potential cash flow constraints and asset quality risks, requiring immediate management intervention to normalize receivables collection and inventory turnover to industry-competitive levels of 85 days and 112 days respectively. Balance sheet conservatism with equity ratio of 72.8%, current ratio of 262.1%, and interest coverage of 31.10 times provides financial flexibility to weather operational headwinds, though long-term debt increase of 43.5% YoY and elevated dividend payout ratio of 76.1% warrant monitoring for capital allocation sustainability amid profit pressure and limited FCF margin of 16.4B yen after 45.3B yen estimated CapEx investment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.